194 related articles for article (PubMed ID: 9751013)
1. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and PreS subunit vaccine for immunization of healthy adults.
Eyigün CP; Yilmaz S; Gül C; Sengül A; Hacibektasoglu A; Van Thiel DH
J Viral Hepat; 1998 Jul; 5(4):265-9. PubMed ID: 9751013
[TBL] [Abstract][Full Text] [Related]
2. Antibody responses to preS components after immunization of children with low doses of BioHepB.
Madalinski K; Sylvan SP; Hellström U; Mikolajewicz J; Zembrzuska-Sadkowska E; Piontek E
Vaccine; 2001 Oct; 20(1-2):92-7. PubMed ID: 11567751
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.
Leroux-Roels G; Desombere I; De Tollenaere G; Petit MA; Desmons P; Hauser P; Delem A; De Grave D; Safary A
Vaccine; 1997 Nov; 15(16):1724-31. PubMed ID: 9364674
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus vaccination for older adults.
Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
[TBL] [Abstract][Full Text] [Related]
7. PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac vaccine and their relation to the antibody response to hepatitis B surface antigen.
Hellström UB; Madalinski K; Sylvan SP
Virol J; 2009 Jan; 6():7. PubMed ID: 19154574
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.
Leroux-Roels G; Desombere I; Cobbaut L; Petit MA; Desmons P; Hauser P; Delem A; De Grave D; Safary A
Vaccine; 1997 Nov; 15(16):1732-6. PubMed ID: 9364675
[TBL] [Abstract][Full Text] [Related]
9. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
[TBL] [Abstract][Full Text] [Related]
10. Presence of anti-preS1, anti-preS2, and anti-HBs antibodies in newborns immunized with Bio-Hep-B vaccine.
Madaliński K; Sylvan SP; Hellstrom U; Mikołajewicz J; Dzierzanowska-Fangrat K
Med Sci Monit; 2004 Jan; 10(1):PI10-7. PubMed ID: 14704645
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine.
Rendi-Wagner P; Shouval D; Genton B; Lurie Y; Rümke H; Boland G; Cerny A; Heim M; Bach D; Schroeder M; Kollaritsch H
Vaccine; 2006 Apr; 24(15):2781-9. PubMed ID: 16455169
[TBL] [Abstract][Full Text] [Related]
12. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
Raz R; Koren R; Bass D
Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.
Katkov WN; Watkins E; DeMelia HC; Dienstag JL
J Viral Hepat; 1994; 1(1):79-83. PubMed ID: 8790563
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines.
Zuckerman JN; Zuckerman AJ; Symington I; Du W; Williams A; Dickson B; Young MD;
Hepatology; 2001 Oct; 34(4 Pt 1):798-802. PubMed ID: 11584378
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
19. Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunization.
Coursaget P; Buisson Y; Bourdil C; Yvonnet B; Molinié C; Diop MT; Chiron JP; Bao O; Diop-Mar I
Res Virol; 1990; 141(5):563-70. PubMed ID: 2148981
[TBL] [Abstract][Full Text] [Related]
20. [Simultaneous expression of modified hepatitis B surface antigen fusion polypeptides containing preS1, preS2 epitopes in Pichia pastoris].
Tan CY; Jiang LM; Ge YH; Yuan J; Jin O; Hu B
Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):604-8. PubMed ID: 16894895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
